logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Clarke, Anthony, Dr

    Related profiles found in government register
  • Clarke, Anthony, Dr
    British born in November 1955

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • Clarke, Anthony
    British born in November 1955

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • Clarke, Anthony, Dr
    born in November 1955

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • Anthony Clarke
    British born in November 1955

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • Clarke, Anthony, Dr
    British

    Registered addresses and corresponding companies
child relation
Offspring entities and appointments 9
  • 1
    ACHIEVE PHARMA UK LIMITED
    - now 06751116
    EXTAB PHARMA LIMITED - 2016-01-28
    ABTEX PHARMA LIMITED - 2009-09-18
    Active Corporate (5 parents)
    Person with significant control
    2016-04-06 ~ 2017-08-01
    IIF 10 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 10 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 2
    AESCLEPIUS PHARMA LIMITED
    SC451780
    Dissolved Corporate (3 parents)
    Officer
    2013-06-06 ~ dissolved
    IIF 3 - Director → ME
  • 3
    ALEXZA UK LIMITED
    06615077
    Dissolved Corporate (6 parents)
    Officer
    2008-12-09 ~ 2011-06-08
    IIF 12 - Secretary → ME
  • 4
    LIPSIUS PHARMA LIMITED
    14013672
    Dissolved Corporate (2 parents)
    Officer
    2022-03-30 ~ dissolved
    IIF 6 - Director → ME
    Person with significant control
    2022-03-30 ~ dissolved
    IIF 9 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 9 - Ownership of shares – More than 25% but not more than 50% → OE
  • 5
    PLAN B PHARMA LIMITED
    09340363
    Dissolved Corporate (3 parents)
    Officer
    2014-12-04 ~ dissolved
    IIF 2 - Director → ME
  • 6
    RENOWN PHARMA LIMITED
    09927036
    Active Corporate (3 parents, 1 offspring)
    Officer
    2015-12-22 ~ now
    IIF 4 - Director → ME
    Person with significant control
    2016-04-06 ~ now
    IIF 11 - Has significant influence or control → OE
  • 7
    RICANTO LIMITED
    07055288
    Active Corporate (2 parents)
    Officer
    2009-10-23 ~ now
    IIF 1 - Director → ME
    Person with significant control
    2016-04-06 ~ now
    IIF 8 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 8 - Ownership of shares – More than 25% but not more than 50% → OE
  • 8
    US3 PARTNERSHIP LLP
    OC353180
    Active Corporate (4 parents)
    Officer
    2010-03-12 ~ 2016-01-29
    IIF 7 - LLP Designated Member → ME
  • 9
    ZOGENIX INTERNATIONAL LIMITED - now
    BRABANT PHARMA LIMITED
    - 2015-11-17 08330213
    Active Corporate (24 parents)
    Officer
    2013-01-15 ~ 2014-10-24
    IIF 5 - Director → ME

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.